Literature DB >> 23018017

The spectrum of reticulate pigment disorders of the skin revisited.

Cornelia S L Müller1, Lea Tremezaygues, Claudia Pföhler, Thomas Vogt.   

Abstract

Within the group of classical reticulate pigment disorders of the skin, Galli-Galli disease (GGD), Dowling-Degos disease (DDD), Kitamura's disease (RPK), Haber's syndrome (HS), and reticulate acropigmentation of Dohi (RAD) are included and distinguished clinically and histopathologically. The clinical appearance of the reticulate pigment disorders of the skin is similar, with slight differences in age of onset and associated disorders. The histopathologic features of reticulate pigment disorders of the skin are comparable, with the exception of the unique hallmark of suprabasal acantholysis, which can be observed exclusively in GGD. Based on a critical discussion, we recommend using major and minor defining criteria for diagnosing skin lesions compatible with the reticulate pigment dermatoses of the skin. Herein we discuss a unifying nosological concept to provide straightforward diagnoses of the reticulate pigment disorders of the skin with a therapeutic impact.

Entities:  

Mesh:

Year:  2012        PMID: 23018017     DOI: 10.1684/ejd.2012.1829

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  7 in total

1.  Reticulate acropigmentation of Kitamura: A familial case with eyelid involvement.

Authors:  Preema Sinha; Anamika Sinha; Sukriti Baveja; Manas Chatterjee
Journal:  Med J Armed Forces India       Date:  2014-08-14

2.  Hcfc1b, a zebrafish ortholog of HCFC1, regulates craniofacial development by modulating mmachc expression.

Authors:  Anita M Quintana; Elizabeth A Geiger; Nate Achilly; David S Rosenblatt; Kenneth N Maclean; Sally P Stabler; Kristin B Artinger; Bruce Appel; Tamim H Shaikh
Journal:  Dev Biol       Date:  2014-10-02       Impact factor: 3.582

3.  Dyschromatosis symmetrica hereditaria of late onset?

Authors:  Caroline Balvedi Gaiewski; Sergio Zuneda Serafini; Betina Werner; Janyana M D Deonizio
Journal:  Case Rep Dermatol Med       Date:  2014-02-04

4.  Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease.

Authors:  N J Wilson; C Cole; K Kroboth; W N Hunter; J A Mann; W H I McLean; K Kernland Lang; H Beltraminelli; R A Sabroe; N Tiffin; G J Sobey; L Borradori; E Simpson; F J D Smith
Journal:  Br J Dermatol       Date:  2016-09-24       Impact factor: 9.302

5.  Acitretin therapy for Galli-Galli disease.

Authors:  Chandler W Rundle; Solveig Ophaug; Eric L Simpson
Journal:  JAAD Case Rep       Date:  2020-04-30

6.  The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.

Authors:  Shyam Verma; Sandra M Pasternack; Arno Rütten; Thomas Ruzicka; Regina C Betz; Sandra Hanneken
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

7.  Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease.

Authors:  A K Reisenauer; S V Wordingham; J York; E W J Kokkonen; W H I Mclean; N J Wilson; F J D Smith
Journal:  Br J Dermatol       Date:  2014-06       Impact factor: 9.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.